Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of molecular testing in advanced melanoma on outcomes in a tertiary cancer center and as reported in a publicly available database.

Cancer reports (Hoboken, N.J.) - 1 Aug 2021

Dimitrova Maya, Kim Min Jae, Osman Iman, Jour George

Abstract excerpt

BACKGROUND: In patients with advanced melanoma (MM), genomic profiling may guide treatment decisions in the frontline setting and beyond as specific tumor mutations can be treated with targeted therapy (TT). The range of panel sizes used to identify targetable mutations (TM) can range from a few dozen to whole exome sequencing (WES). AIM: We investigated the impact of panel size and mutation status on first-line...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Exome Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Melanoma

Share to Molecular Diagnostic Techniques

Share to Molecular Targeted Therapy

Share to Skin Neoplasms

Share to Tertiary Care Centers

Source

Open in PubMed Open full text

Identifiers

PMID: 34109763
DOI: 10.1002/cnr2.1380
PMCID: PMC8388178

Genes

BRAF
IMPACT
NRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of molecular testing in advanced melanoma on outcomes in a tertiary cancer center and as reported in a publicly available database.PMID 34109763Read ↗

Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma.Semantic proximity Read ↗

Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.Semantic proximity Read ↗

The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response.Semantic proximity Read ↗

A Melanoma-Tailored Next-Generation Sequencing Panel Coupled with a Comprehensive Analysis to Improve Routine Melanoma Genotyping.Semantic proximity Read ↗

Using Genomic Sequencing to Improve Management in Melanoma.Semantic proximity Read ↗

Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy.Semantic proximity Read ↗

Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive AlterationsSemantic proximity Read ↗

Molecular testing in malignant melanoma.Semantic proximity Read ↗

New strategies in melanoma: molecular testing in advanced disease.Semantic proximity Read ↗

Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.Semantic proximity Read ↗

A high-throughput panel for identifying clinically relevant mutation profiles in melanoma.Semantic proximity Read ↗

Validation of an NGS mutation detection panel for melanomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.